Business Description
SyntekaBio Inc
ISIN : KR7226330009
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 9.39 | |||||
Equity-to-Asset | 0.59 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | -0.23 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 2.01 | |||||
Beneish M-Score | -2.72 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -42.8 | |||||
3-Year EBITDA Growth Rate | -17 | |||||
3-Year EPS without NRI Growth Rate | -19.8 | |||||
3-Year FCF Growth Rate | -42.8 | |||||
3-Year Book Growth Rate | -13 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 27.09 | |||||
9-Day RSI | 37.18 | |||||
14-Day RSI | 41.02 | |||||
6-1 Month Momentum % | -3.63 | |||||
12-1 Month Momentum % | 43.92 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.13 | |||||
Quick Ratio | 1.13 | |||||
Cash Ratio | 1.01 | |||||
Days Sales Outstanding | 2.16 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.5 | |||||
Shareholder Yield % | 2.08 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -9947.89 | |||||
Net Margin % | -9235.89 | |||||
FCF Margin % | -14187.03 | |||||
ROE % | -32.36 | |||||
ROA % | -19.28 | |||||
ROIC % | -29.48 | |||||
ROC (Joel Greenblatt) % | -45.22 | |||||
ROCE % | -27.7 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1232.51 | |||||
PB Ratio | 4.9 | |||||
Price-to-Tangible-Book | 4.97 | |||||
EV-to-EBIT | -12.27 | |||||
EV-to-EBITDA | -14.62 | |||||
EV-to-Revenue | 1096.71 | |||||
EV-to-FCF | -8.22 | |||||
Price-to-Net-Current-Asset-Value | 525.1 | |||||
Earnings Yield (Greenblatt) % | -8.14 | |||||
FCF Yield % | -11.45 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
SyntekaBio Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 123.406 | ||
EPS (TTM) (â‚©) | -835 | ||
Beta | 1.6 | ||
Volatility % | 76.09 | ||
14-Day RSI | 41.02 | ||
14-Day ATR (â‚©) | 513.010202 | ||
20-Day SMA (â‚©) | 10567.5 | ||
12-1 Month Momentum % | 43.92 | ||
52-Week Range (â‚©) | 7330 - 19960 | ||
Shares Outstanding (Mil) | 15.23 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
SyntekaBio Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
SyntekaBio Inc Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
SyntekaBio Inc Frequently Asked Questions
What is SyntekaBio Inc(XKRX:226330)'s stock price today?
When is next earnings date of SyntekaBio Inc(XKRX:226330)?
Does SyntekaBio Inc(XKRX:226330) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |